Gadolinium-conjugated TiO2-DNA Oligonucleotide Nanoconjugates Show Prolonged Intracellular Retention Period and T1-weighted Contrast Enhancement in Magnetic Resonance Images.

Tatjana Paunesku,Tianyi Ke,Rohan Dharmakumar,Nicole Mascheri,Aiguo Wu,Barry Lai,Stefan Vogt,Joerg Maser,Kenneth Thurn,Barbara Szolc-Kowalska,Andrew Larson,Raymond C. Bergan,Reed Omary,Debiao Li,Zheng-Rong Lu,Gayle E. Woloschak
DOI: https://doi.org/10.1016/j.nano.2008.04.004
IF: 6.458
2008-01-01
Nanomedicine Nanotechnology Biology and Medicine
Abstract:Nanoconjugates composed of titanium dioxide (TiO2) nanoparticles, DNA oligonucleotides, and a gadolinium (Gd) contrast agent were synthesized for use in magnetic resonance imaging. Transfection ofculturedcancercellswiththesenanoconjugatesshowedthemtobesuperiortothefreecontrastagent of the same formulation with regard to intracellular accumulation, retention, and subcellular localization. Our results have shown that 48 hours after treatment, the concentration of Gd in nanoconjugate-treated cells was 1000-fold higher than in cells treated with contrast agent alone. Consequently,T1-weightedcontrast enhancementswere observedincellstreated withnanoconjugates but not in cells treated by the contrast agent alone. This type of nanoconjugate with increased retention time,Gdaccumulation,andintracellulardeliverymayfinditsuseinGdneutron-capturecancertherapy.
What problem does this paper attempt to address?